You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ROIV Exercise Disclosure
Sukhatme Mayukh · SEC Form 4 · Filed Aug 21, 2026
Exercise
Calculated transaction value
$0
Sukhatme Mayukh President & CIO
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Aug 21, 2026
Public filing date
Aug 21, 2026
Filing lag
Filed same day
ROIV daily price context
Close on/before transaction
$36.3
Aug 21, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Shares
- Quantity / price
- 144,756 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001140361-26-034066
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$13.65M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV Current | Exercise | Aug 21, 2026 | $0 |
| Roivant Sciences Ltd. ROIV | Sale | Aug 21, 2026 | $5.28M |
| Roivant Sciences Ltd. ROIV | Exercise | Aug 21, 2026 | $557.31K |
| Roivant Sciences Ltd. ROIV | Sale | Aug 20, 2026 | $653.46K |
| Roivant Sciences Ltd. ROIV | Exercise | Aug 20, 2026 | $67.45K |
| Roivant Sciences Ltd. ROIV | Exercise | Aug 20, 2026 | $0 |
| Roivant Sciences Ltd. ROIV | Exercise | Aug 19, 2026 | $665.66K |
| Roivant Sciences Ltd. ROIV | Sale | Aug 19, 2026 | $6.43M |
| Roivant Sciences Ltd. ROIV | Exercise | Aug 19, 2026 | $0 |